Boehringer Ingelheim and Eli Lilly Partner with the American Kidney Fund
The American Kidney Fund (AKF) has recently announced an exciting partnership with Boehringer Ingelheim and Eli Lilly and Company. Both organizations have joined the 2024 class of AKF’s Corporate Membership Program, achieving the esteemed Champion-level membership. This collaboration is designed to boost awareness, prevention, early detection, treatment, and research related to kidney disease.
Backing Kidney Health Initiatives
LaVarne A. Burton, President and CEO of AKF, expressed appreciation for the enduring partnership with Boehringer Ingelheim and Lilly. "Their generous support has empowered us to create top-notch educational programs like Kidney Action Week and Know Your Kidneys, which provide essential information and resources for individuals to take control of their kidney health," Burton remarked.
Key Programs by AKF
Boehringer Ingelheim and Lilly have been vital supporters of AKF’s Kidney Action Week, a free virtual conference that unites patients, caregivers, nephrologists, researchers, and other experts for a series of informative sessions centered on kidney health. This initiative offers invaluable insights and resources to help those affected by kidney disease.
Know Your Kidneys Education Program
In addition to Kidney Action Week, Boehringer Ingelheim and Lilly have actively backed the Know Your Kidneys education program. Launched in 2019, this initiative aims to raise awareness about kidney disease and associated health issues. Recently, the program has expanded to include additional educational modules that support communities throughout the entire kidney disease journey, from prevention to post-transplant care.
Dedication to Disease Awareness and Support
Brian DiDonato, Senior Vice President of the Cardio-Renal-Metabolic Franchise at Boehringer Ingelheim, highlighted their commitment to advancing kidney health. "The Boehringer Ingelheim and Lilly Alliance is proud to support the AKF's efforts by joining the Corporate Membership Program at the champion level for the third consecutive year. Today’s announcement reinforces our dedication to raising awareness about kidney disease and implementing impactful initiatives that aim to improve care for millions affected by these conditions," DiDonato stated.
Enhancing Health Equity in Kidney Disease
This partnership also emphasizes health equity in kidney disease through the Kidney Health for All initiative, which seeks to engage racial and ethnic minority groups that are disproportionately impacted by end-stage renal disease. This initiative is a crucial part of AKF’s mission to address kidney disease across diverse communities.
Funding Award-Winning Educational Programs
By joining the Corporate Membership Program, Boehringer Ingelheim and Lilly contribute to AKF's award-winning educational programs and resources. These initiatives support individuals in their battle against kidney disease, ensuring that essential resources are accessible to those who need them most.
AKF's Comprehensive Approach to Kidney Disease
The American Kidney Fund plays a vital role in tackling kidney disease through a comprehensive strategy that includes early detection, disease management, financial assistance, clinical research, innovation, and advocacy. Renowned for its exceptional service, AKF supports approximately 1 in 7 Americans affected by kidney disease, along with millions more who are at risk.
AKF has established itself as a leading nonprofit organization, investing 97 cents of every donated dollar into programs and services while maintaining the highest 4-Star rating from Charity Navigator for 21 consecutive years. Additionally, AKF has earned the Platinum Seal of Transparency from Candid, underscoring its commitment to transparency and effective resource use.
Contact Information
For further details about the Corporate Membership Program, potential partners can reach out to Daniel Green, the corporate engagement manager, by contacting him directly via email or phone. He is available at dgreen@kidneyfund.org or by calling 301-984-6675.
Frequently Asked Questions
What is the American Kidney Fund (AKF)?
The American Kidney Fund is a nonprofit organization dedicated to combating kidney disease through education, financial assistance, and support for research and innovation.
What does the Champion-level membership in AKF signify?
The Champion-level membership indicates a significant commitment from organizations to support AKF's mission and initiatives aimed at enhancing kidney health and awareness.
How do Boehringer Ingelheim and Eli Lilly support kidney health initiatives?
They provide financial backing and resources for educational programming and partnerships focused on kidney disease, which help to ensure better health outcomes and advocacy efforts.
What programs does AKF offer to promote kidney health?
AKF offers a range of programs, including Kidney Action Week and Know Your Kidneys, designed to raise awareness and provide education about kidney health.
How can individuals get involved with AKF?
Individuals can engage with AKF by participating in programs, volunteering, or supporting fundraising efforts to advance the fight against kidney disease.
